Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Seeger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Medicine and Science in Sports and Exercise|August 1, 1986
In vivo opioid receptor occupation in the rat brain following exerciseG A Sforzo, T F Seeger, C B Pert, et al.
Brain Research|September 21, 1979
Denervation supersensitivity in the mesolimbic system: involvement of dopamine-stimulated adenylate cyclaseM R Rosenfeld, T F Seeger, N S Sharpless, et al.
Science (New York, N.Y.)|April 20, 1984
Metabolic mapping of the brain during rewarding self-stimulationL J Porrino, R U Esposito, T F Seeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Changes in local cerebral glucose utilization during rewarding brain stimulationR U Esposito, L J Porrino, T F Seeger, et al.
Journal of Medicinal Chemistry|October 15, 1993
Synthesis, in vitro binding profile, and autoradiographic analysis of [3H]-cis-3-[(2-methoxybenzyl)amino]-2-phenylpiperidine, a highly potent and selective nonpeptide substance P receptor antagonist radioligandT Rosen, T F Seeger, S McLean, et al.
Science (New York, N.Y.)|January 25, 1991
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonistS McLean, A H Ganong, T F Seeger, et al.
Journal of Medicinal Chemistry|November 1, 1990
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazoleT Rosen, T F Seeger, S McLean, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|June 1, 1991
1-Naphthylpiperazine derivatives as potential atypical antipsychotic agentsJ A Lowe, T F Seeger, A A Nagel, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Medicine and Science in Sports and Exercise|August 1, 1986
In vivo opioid receptor occupation in the rat brain following exerciseG A Sforzo, T F Seeger, C B Pert, et al.
Brain Research|September 21, 1979
Denervation supersensitivity in the mesolimbic system: involvement of dopamine-stimulated adenylate cyclaseM R Rosenfeld, T F Seeger, N S Sharpless, et al.
Science (New York, N.Y.)|April 20, 1984
Metabolic mapping of the brain during rewarding self-stimulationL J Porrino, R U Esposito, T F Seeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Changes in local cerebral glucose utilization during rewarding brain stimulationR U Esposito, L J Porrino, T F Seeger, et al.
Journal of Medicinal Chemistry|October 15, 1993
Synthesis, in vitro binding profile, and autoradiographic analysis of [3H]-cis-3-[(2-methoxybenzyl)amino]-2-phenylpiperidine, a highly potent and selective nonpeptide substance P receptor antagonist radioligandT Rosen, T F Seeger, S McLean, et al.
Science (New York, N.Y.)|January 25, 1991
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonistS McLean, A H Ganong, T F Seeger, et al.
Journal of Medicinal Chemistry|November 1, 1990
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazoleT Rosen, T F Seeger, S McLean, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|June 1, 1991
1-Naphthylpiperazine derivatives as potential atypical antipsychotic agentsJ A Lowe, T F Seeger, A A Nagel, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
Pageof 2